Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

53.4K
Overview
53.4K
Physiological Barriers01:25

Physiological Barriers

5.3K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.3K
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

4.8K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intratympanic Application of Betahistine for Menière Disease-An Animal Study on Safety and Diffusion to the Inner Ear.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

In Response to Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?

The Laryngoscope·2026
Same author

In-office balloon dilation for baro-challenge-induced Eustachian tube dysfunction: study protocol for a randomized sham-controlled trial.

Trials·2026
Same author

Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.

Scientific reports·2025
Same author

Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?

The Laryngoscope·2025
Same author

Magnetic Targeting of AAV Gene Therapy for Inner Ear Following Systemic Delivery: Preliminary Findings and Transduction Pattern in Rat Cochlea.

Journal of the Association for Research in Otolaryngology : JARO·2025

Related Experiment Video

Updated: Feb 17, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.8K

Mannitol and the blood-labyrinth barrier.

Trung N Le1,2, Brian W Blakley3

  • 1Department of Otolaryngology - Head & Neck Surgery, Sunnybrook Research Institute, University of Toronto, 2075 Bay view Ave., Room M1.102, Toronto, ON, M4N 3M5, Canada. trungngocle@gmail.com.

Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale
|December 13, 2017
PubMed
Summary

Mannitol transiently increases the permeability of the blood labyrinth barrier (BLB), aiding gentamicin entry and exit. This finding suggests potential clinical benefits for drug delivery to the inner ear.

Keywords:
Blood brain barrierBlood labyrinth barrierCerebrospinal fluidGentamicinMannitolPerilymphPermeabilityPharmacokinetics

More Related Videos

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues
09:10

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues

Published on: January 12, 2024

3.7K
An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers
09:35

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Published on: February 26, 2018

26.4K

Related Experiment Videos

Last Updated: Feb 17, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.8K
Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues
09:10

Author Spotlight: Advancing the Use of Tissue Chip Technology for Studying Human Tissues

Published on: January 12, 2024

3.7K
An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers
09:35

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Published on: February 26, 2018

26.4K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Otolaryngology

Background:

  • Characterizing the blood labyrinth barrier (BLB) is crucial for pharmacological manipulation.
  • Investigating the BLB is technically challenging.
  • This study introduces a novel method for BLB control and pharmacokinetic analysis.

Purpose of the Study:

  • To establish the pharmacokinetics of gentamicin in perilymph, cerebrospinal fluid (CSF), and blood.
  • To evaluate the effect of mannitol on BLB and blood-brain barrier (BBB) permeability to gentamicin.

Main Methods:

  • A controlled animal research project involving 44 guinea pigs.
  • Measurement of gentamicin concentrations in blood, perilymph, and CSF with and without mannitol administration.
  • Pharmacokinetic analysis of 175 samples collected over 17.5 hours post-infusion.

Main Results:

  • Mannitol significantly increased gentamicin's entry and egress through the BLB (p=0.0044).
  • Mannitol's effect on the blood-brain barrier (BBB) was not statistically significant (p=0.581).
  • Gentamicin concentrations in perilymph and CSF remained lower than in blood.

Conclusions:

  • Mannitol administration temporarily enhances BLB permeability.
  • Strategic timing of mannitol may improve drug delivery (e.g., gentamicin) into the perilymph.
  • Findings suggest potential clinical applications for osmotic agents in modulating inner ear drug concentrations.